Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: A mixed method study

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Birmingham, Wendy C ^a   Agarwal, Neeraj ^b,c   Kohlmann, Wendy ^b   Aspinwall, Lisa G ^d   Wang, Mary ^b   Bishoff, Jay ^e   Dechet, Christopher ^b,d   Kinney, Anita Y ^b,c  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

Attitudes; Cancer screening; Genomics; Prostate cancer; Providers

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; GENERAL PRACTITIONER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEALTH CARE SURVEY; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; UNITED STATES;

AGED; FOCUS GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PROSTATIC NEOPLASMS; UTAH;

EID: 84880335080     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-279     Document Type: Article

References (46)

1. Cancer statistics, 2012. Siegel R, Naishadham D, Jemal A, CA Cancer J Clin 2012 62 1 10 29
2. American Cancer S, Cancer Facts & Figures 2012 American Cancer Society: Atlanta, GA 2012
3. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Zeegers MP, Jellema A, Ostrer H, Cancer 2003 97 8 1894 1903 (Pubitemid 36397263)
4. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Brandt A, Bermejo JL, Sundquist J, Hemminki K, Eur Urol 2010 58 2 275 280
5. ACS, American Cancer Society. Cancer Facts & Figures 2012 Atlanta: American Cancer Society 2012
6. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Moyer VA, Ann Intern Med 2012 157 2 120 134
7. Genome-wide association studies in common cancers-what have we learnt? Varghese JS, Easton DF, Curr Opin Genet Dev 2010 20 3 201 209
8. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, et al. Nat Genet 2011 43 11 1098 1103
9. Genetic correction of PSA values using sequence variants associated with PSA levels. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, et al. Sci Transl Med 2010 2 62 62ra 92
10. Cumulative association of five genetic variants with prostate cancer. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, et al. N Engl J Med 2008 358 9 910 919 (Pubitemid 351397090)
11. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. McGuire AL, Burke W, JAMA 2008 300 22 2669 2671
12. Common genetic variation and human traits. Goldstein DB, N Engl J Med 2009 360 17 1696 1698
13. Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Goldsmith L, Jackson L, O'Connor A, Skirton H, Eur J Hum Genet 2012 21 1 113 126
14. Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD, Public Health Genomics 2011 14 3 178 189
15. What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Sanderson SC, O'Neill SC, Bastian LA, Bepler G, McBride CM, Public Health Genomics 2010 13 2 116 124
16. Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. Powell KP, Cogswell WA, Christianson CA, Dave G, Verma A, Eubanks S, Henrich VC, J Genet Couns 2012 21 1 113 126
17. Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands. Cremers R, van Asperen C, Kil P, Vasen H, Wiersma T, van Oort I, Kiemeney L, Fam Cancer 2011 11 2 195 200
18. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Baars MJ, Henneman L, Ten Kate LP, Genet Med 2005 7 9 605 610 (Pubitemid 41753011)
19. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Kolor K, Liu T, St Pierre J, Khoury MJ, Genet Med 2009 11 8 595
20. Genetic testing in primary care. Burke W, Annu Rev Genomics Hum 2004 5 1 15
21. Holtzman NA, Watson MS, Promoting safe and effective genetic testing in the United States Bethesda, Md: National Human Genome Research Institute 1997
22. The primary care physician role in cancer genetics: a qualitative study of patient experience. Miller FA, Carroll JC, Wilson BJ, Bytautas JP, Allanson J, Cappelli M, de Laat S, Saibil F, Fam Pract 2010 27 5 563 569
23. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, Callif-Daley F, Grumet SC, Hunt KS, Nagy RS, et al. J Genet Couns 2012 21 2 151 161
24. Krueger RA, Casey MA, Focus groups: A practical guide to applied research Thousand Oaks, CA: Sage 2009
25. The newfound credibility of qualitative research? Tales of technical essentialism and co-option. Barbour RS, Qual Health Res 2003 13 7 1019 1027 (Pubitemid 44534759)
26. The Cancer Genetics Network: recruitment results and pilot studies. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, et al. Community Genet 2003 6 3 171 177 (Pubitemid 38916116)
27. Grounded Theory as an Emergent Method. Charmaz K, The Handbook of Emergent Methods New York: Guilford, Hesse-Biber SN, Leavy P, 2008 155 170
28. Glaser BG, Strauss AL, The Discovery of Grounded Theory: Strategies for Qualitative Research Chicago: Aldine 1967
29. Translational research in cancer genetics: the road less traveled. Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ, Public Health Genomics 2011 14 1 1 8
30. How can we stimulate translational research in cancer genomics beyond bench to bedside? Schully SD, Benedicto CB, Khoury MJ, Genet Med 2012 14 1 169 170
31. Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century. Khoury MJ, Clauser SB, Freedman AN, Gillanders EM, Glasgow RE, Klein WM, Schully SD, Cancer Epidemiol Biomarkers Prev 2011 20 10 2105 2114
32. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L, Genet Med 2007 9 10 665 674 (Pubitemid 350287151)
33. Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Bloss CS, Ornowski L, Silver E, Cargill M, Vanier V, Schork NJ, Topol EJ, Genet Med 2010 12 9 556 566
34. Social networkers' attitudes toward direct-to-consumer personal genome testing. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG, The American journal of bioethics: AJOB 2009 9 6-7 3 10
35. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Gollust SE, Gordon ES, Zayac C, Griffin G, Christman MF, Pyeritz RE, Wawak L, Bernhardt BA, Public Health Genomics 2012 15 1 22 30
36. Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. Haga SB, Carrig MM, O'Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS, Cho A, J Gen Intern Med 2011 26 8 834 840
37. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients. Ngoi N, Lee SC, Hartman M, Khin LW, Wong A, Breast 2012 22 1 47 52
38. A survey of UK public interest in internet-based personal genome testing. Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B, PLoS One 2010 5 10 13473
39. A randomized trial of genetic information for personalized nutrition. Nielsen DE, El-Sohemy A, Genes Nutr 2012 7 4 559 566
40. Diet, lifestyle and risk of prostate cancer. Wolk A, Acta Oncol 2005 44 3 277 281 (Pubitemid 40904131)
41. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Fakhrabadi-Shokoohi D, Giovannucci EL, Thun MJ, Calle EE, Cancer Epidemiol Biomarkers Prev 2003 12 7 597 603 (Pubitemid 36899838)
42. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Tseng M, Breslow RA, Graubard BI, Ziegler RG, Am J Clin Nutr 2005 81 5 1147 1154 (Pubitemid 41724958)
43. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB, Cancer Epidemiol Biomarkers Prev 2007 16 12 2623 2630 (Pubitemid 351196317)
44. Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study. Major JM, Cross AJ, Watters JL, Hollenbeck AR, Graubard BI, Sinha R, Cancer Causes Control 2011 22 12 1691 1698
45. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome. Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA, Psycho-Oncology 2011 22 2 276 289
46. Screening for prostate cancer: the current evidence and guidelines controversy. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R, Can J Urol 2011 18 5 5875 5883